RE: MRI scanners3 Mar 2024 13:07
Can they sell the software though without the CPT code? The 13th Oct letter told investors that hospital admin couldn't warrant buying it as they can't be reimbursed themselves without it. It also stated bayer and their other sales partners were eagerly awaiting it too presumably so they can sell it?
That's why I thought the May date for final decision on the CPT was so important to the co. and also why I have my suspicions that FAB sold the spike because they were given inside info on the fact they'd been knocked back and weren't planning to reapply til end of this year.
Would love someone with more knowledge to come along and tell me I'm wrong as I'm still holding but bar that happening am only really expecting any large revenue streams this year to come through grants.
"Earlier this year, we made the strategic decision to apply for a Current Procedure Terminology (CPT) code specific to the DSC perfusion technology available in IB Neuro. CPT codes are assigned and maintained by the American Medical Association (AMA). They are used to track and bill medical services for payer reimbursement. Like regulatory clearance, CPT codes are a critical aspect in achieving widespread commercial adoption in healthcare. Currently, a few of our clients are using a general, non-specific CPT code to get reimbursed for the MRI procedures that rely on IB Neuro, but only a limited few. This lack of a reimbursement pathway makes it more difficult for hospital administrators to justify investing in IB products. Fortunately, enough scientific and clinical validation have been performed by our co-founder, Kathleen Schmainda, PhD and her colleagues over the years, and a growing number of sites are routinely using IB Neuro as the standard of care, to warrant a dedicated CPT code. The application is due in early November and a final decision will be made in May 2024. A CPT code will help make for easier buying decisions for healthcare administrators."
"These gains in clinical efficiency dovetail perfectly with our strategy of making IB products accessible on larger, more comprehensive platforms, such as those offered by GE Healthare, Bayer, TeraRecon, and our other partners. Currently, we are working very closely with each of them in preparation for a busy tradeshow season. And, as you can imagine, all our partners share in our excitement of potentially receiving a CPT code for IB Neuro."